Anthony J. Costello | |
---|---|
Born | Melbourne, Australia |
Known for | Robotic surgery |
Medical career | |
Institutions | |
Awards |
Anthony James Costello, FRACS, FRCSI, is an Australian urologist. He served as head of the department of urology at the Royal Melbourne Hospital, Australia. He established the first robotic prostate cancer surgery programme in Australia and published the first series of men who had laser surgery for benign prostate enlargements.
Costello has been an advocate for PSA testing in men and robotic surgery for prostate removal in treating prostate cancer. Based on microdissections of cadavers, he described the anatomy of the nerves near the prostate, significant for preserving erectile function.
Anthony Costello was born in St Vincent's Hospital, Melbourne. His father was an Australian Air Force pilot and general practitioner who practiced from home, where his mother stayed with their eight children. His ancestors had emigrated from Ireland in the mid 1800s. [1]
Between 1957 and 1966 he attended Xavier College, and then studied at Newman College, a residential college of the University of Melbourne. He gained his medical degree in 1972 from the University of Melbourne, Medical School. [1] [2]
In 1981 Costello completed a fellowship at MD Anderson Cancer Center in Houston, under the supervision of urological surgeon Douglas E. Johnson. Subsequently, he spent five years back in Melbourne and then took a sabbatical as a returning fellow in Houston in 1989, when he developed an interest in emerging technologies relating to prostate cancer. He then returned to Melbourne in 1990 and became head of the unit at St. Vincent's. [1] [2] [3]
He established an international urologic-oncology fellowship programme. [4] In 1992, he published the first series of men who had laser surgery for benign prostate enlargements using the Nd:YAG laser. [5] In 1999, he was appointed head of urology at the Royal Melbourne Hospital, where, in 2001, he established a laboratory for prostate cancer research at its Department of Surgery. He also helped establish the Victorian Prostate Cancer Foundation. [1] [6]
In 2003, he began using the da Vinci Surgical robot for prostate surgery at his private practice in Epworth Hospital in Richmond, and established the first robotic prostate cancer surgery programme in Australia. [1] [4]
Costello has been an advocate for PSA testing in men and robotic surgery for prostate removal in treating prostate cancer. [7] [8] He popularised the use of an endoscopic closure device for raising the prostate during robotic assisted radical prostatectomy. [9] Based on a series of microdissections of cadavers, he described the anatomy of the nerves near the prostate in detail, significant for preserving erectile function. [10] [11] With his colleagues, he has questioned the neuroanatomy relating to the prostate gland and felt that the nerves located within the "veil of Aphrodite" (veil of tissue) mainly provide the nerve supply to the prostate, rather than to the corpora cavernosa for sexual function. [12] [11] [13] [14]
Urologists he trained include Ben Challacombe and Declan G. Murphy. [15] [16]
Costello is an honorary fellow of the Royal College of Surgeons in Ireland, [17] a member of the American Association of Genitourinary Surgeons, [1] and on the board of the Australian Prostate Centre. [18]
In 2015, he became a member of the Order of Australia “for significant service to medicine in the field of urology as a clinician, administrator and author, to cancer research, and to medical education”. [17] The following year he became the first honorary life member of Irish Association of Urologists. [17]
In 2017 he was awarded the St Pauls Medal by the British Urological Association. [17] [19]
As a student Costello had been captain of football and swimming teams and later took up running. Of his siblings, four became doctors, one a judge and one a teacher. [1]
In his 30s, he owned a vineyard and made wine. He is married and has grandchildren. [1]
Urology, also known as genitourinary surgery, is the branch of medicine that focuses on surgical and medical diseases of the urinary-tract system and the reproductive organs. Organs under the domain of urology include the kidneys, adrenal glands, ureters, urinary bladder, urethra, and the male reproductive organs.
The prostate is both an accessory gland of the male reproductive system and a muscle-driven mechanical switch between urination and ejaculation. It is found in all male mammals. It differs between species anatomically, chemically, and physiologically. Anatomically, the prostate is found below the bladder, with the urethra passing through it. It is described in gross anatomy as consisting of lobes and in microanatomy by zone. It is surrounded by an elastic, fibromuscular capsule and contains glandular tissue, as well as connective tissue.
Prostatectomy is the surgical removal of all or part of the prostate gland. This operation is done for benign conditions that cause urinary retention, as well as for prostate cancer and for other cancers of the pelvis.
Lower urinary tract symptoms (LUTS) refer to a group of clinical symptoms involving the bladder, urinary sphincter, urethra and, in men, the prostate. The term is more commonly applied to men—over 40% of older men are affected—but lower urinary tract symptoms also affect women. The condition is also termed prostatism in men, but LUTS is preferred.
Urology Robotics, or URobotics, is a new interdisciplinary field for the application of robots in urology and for the development of such systems and novel technologies in this clinical discipline. Urology is among the medical fields with the highest rate of technology advances, which for several years has included the use medical robots.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist, oncologist, and principal investigator. Before moving to the Icahn School of Medicine in 2013, he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy, treating patients with prostate, urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon, and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically, he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit; he is on such lists as America's Top Doctors, New York Magazine's Best Doctors, and Who's Who in the World. In 2012, he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology, most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
Douglas S. Scherr, M.D. is an American surgeon and specialist in Urologic Oncology. He is currently the Clinical Director of Urologic Oncology at Weill Cornell Medicine. He also holds an appointment at the Rockefeller University as a Visiting Associate Physician. Scherr was the first physician at Cornell to perform a robotic prostatectomy as well as a robotic cystectomy.
Dr. Michael A. Palese, is an American urologist specializing in robotic, laparoscopic and endoscopic surgery, with a special emphasis on robotic surgeries relating to kidney cancer and kidney stone disease.
Roger Sinclair Kirby FRCS(Urol), FEBU is a British retired prostate surgeon and professor of urology, researcher, writer on men's health and prostate disease, founding editor of the journal Prostate Cancer and Prostatic Diseases and Trends in Urology and Men's Health and a fundraiser for prostate disease charities, best known for his use of the da Vinci surgical robot for laparoscopic prostatectomy in the treatment of prostate cancer. He is a co-founder and president of the charity The Urology Foundation (TUF), vice-president of the charity Prostate Cancer UK, trustee of the King Edward VII's Hospital and as of 2020 is president of the Royal Society of Medicine (RSM), London.
Reed Miller Nesbit was an American urologist, surgeon, and professor. He was Head of the Urology Section of the Department of Surgery at the University of Michigan Medical School in Ann Arbor, Michigan, from 1930–1967. Nesbit was a pioneer of transurethral resection of the prostate. He devised the Nesbit operation for treating Peyronie's disease, and he made prominent contributions to pediatric urology, most notably the Cabot-Nesbit style orchiopexy.
Prokar Dasgupta is an Indian-born British surgeon and academic who is professor of surgery at the surgical academy at King's Health Partners, London, UK. Since 2002, he has been consultant urologist to Guy's Hospital, and in 2009 became the first professor of robotic surgery and urology at King's, and subsequently the chairman of the King's College-Vattikuti Institute of Robotic Surgery.
John M. Fitzpatrick was an Irish urologist, emeritus professor of surgery at the University College Dublin School of Medicine & Medical Science and Head of Research at the Irish Cancer Society.
Vipul R. Patel, FACS is the founder and Medical Director of the Florida Hospital Global Robotics Institute, founder and Vice President of the Society of Robotic Surgery, and founder and Editor Emeritus of The Journal of Robotic Surgery. He is board certified by the American Urological Association and specializes in robotic surgery for prostate cancer. As of June, 2023 he performed his 17,000th robotic-assisted prostatectomy. The large volume of prostatectomies he has performed has enabled him to amass a large amount of statistical evidence regarding the efficacy of robotic techniques which has been used in developing and refining techniques. Patel credits the use of robotic assisted surgery with helping surgeons achieve better surgical outcomes with the "trifecta" of cancer control, continence and sexual function. In the course of his career Patel has led and participated in studies that have resulted in developing improved outcomes for robotic surgery and urologic treatment.
Terence John MillinFRCSI FRCS LRCP was a British-born Irish urological surgeon, who in 1945, introduced a surgical treatment of benign large prostates using the retropubic prostatectomy, later known as the Millin's prostatectomy, where he approached the prostate from behind the pubic bone and through the prostatic capsule, removing the prostate through the retropubic space and hence avoided cutting into the bladder. It superseded the technique of transvesical prostatectomy used by Peter Freyer, where the prostate was removed through the bladder.
The Urology Foundation (TUF) is a charity that works across the UK and Ireland with the aim of improving the knowledge and skills of surgeons who operate on diseases of the male and female urinary-tract system and the male reproductive organs and funds research to improve outcomes of all urological conditions and urological cancers.
Benjamin James Challacombe is a British consultant urological surgeon at Guy's & St Thomas' Hospitals, and at King’s College London, who specialises in the treatment of kidney and prostatic disease using robotic surgery. In 2005, he was part of the team that published the results of a randomised controlled trial of human versus telerobotics in the field of urology and renal transplant, one of the first of its kind.
Declan G. Murphy, FRACS, FRCS, is a urologist, director of the unit for genitourinary oncology and robotic surgery at the Peter MacCallum Cancer Centre in Melbourne, Australia, professor at the Sir Peter MacCallum Department of Oncology at the University of Melbourne, and associate editor of the British Journal of Urology International. In 2010 he introduced robotic surgery for urology to the public sector health services in Victoria, Australia.
The St Peter's Medal is awarded annually by the British Association of Urological Surgeons (BAUS) for contributions to the surgical field of urology.
Mark Emberton is a urologist and prostate cancer research specialist using novel imaging techniques and minimally invasive treatments to improve diagnosis and treatment of prostate cancer.
Kamran Ahmed is a Professor and a Urological Surgeon who is affiliated with Sheikh Khalifa Medical City, Abu Dhabi, UAE, Khalifa University, Abu Dhabi and King's College London, United Kingdom.